ExpreS2ion CEO talking to BioStock about partnering efforts at BIO-Europe
Reading Time: < 1 minute Tue, Nov 05, 2024 08:15 CET Report this content Heading towards phase I studies with breast cancer vaccine candidate ES2B-C001, ExpreS2ion Biotech is actively looking for partners. Also, having a well-validated platform, the company recently announced signing a
Revolutionizing Investment Opportunity for Investors HDFC SKY Launches Zero Brokerage Option for Exchange Traded Fund (ETF) Investments
Reading Time: 2 minutes Mumbai, Maharashtra, India: HDFC SKY, a leading discount brokerage platform, announced that it has slashed the brokerage on purchase of ETFs through the platform to Zero. The initiative is expected to enhance retail investment opportunities for both new and existing clients
Celebrating a Ramsar Site & The Art of Living’s Remarkable Role in Community-led Conservation
Reading Time: 4 minutes This November, Bijnor district marks a historic milestone – its 200th anniversary – with the grand Bijnor Mahotsav on November 8th, 9th, and 10th, 2024. Bringing together people from across the world with ties to Bijnor, the event will not only celebrate the district’s vibrant
Capsol Technologies ASA – Q3 2024: Strengthened CCS business case for emitters drives demand growth
Reading Time: 3 minutes Capsol Technologies ASA, a provider of carbon capture technology to large emitters, today announced its results for Q3 2024. Steady demand growth Revenues up 80% to NOK 21.6 million, compared to same period in 2023. Mature project pipeline up ~60%
How to optimise return potential with Bajaj Finserv Flexi Cap Fund: Tips for investors
Reading Time: 3 minutes Strategic investing is a long game. This is especially so for equity-oriented mutual funds, which can be volatile in the short-term but offer significant wealth-building potential over time. Bajaj Finserv Flexi Cap Fund
Lytix Biopharma – Update from licensing partner Verrica Pharmaceuticals
Reading Time: 2 minutes Oslo, November 5th, 2024: Lytix Biopharma, a Norwegian immuno-oncology company dedicated to being part of tomorrow’s cancer treatment, refers to the third quarter announcement made by its licensing partner Verrica Pharmaceuticals November 4th, 2024. In the release, Verrica Pharmaceuticals
Strong biological performance in the Faroe Islands and successful de-risking in Scotland
Reading Time: 10 minutes The Bakkafrost Group delivered a total operational EBIT of DKK 173 million (DKK 269 million) in Q3 2024. (Figures in parenthesis refer to the same period last year unless otherwise specified) The performance in Q3 2024 per region was as follows:
Parse Biosciences Launches Evercode Low Input Fixation for Cells and Nuclei
Reading Time: 2 minutes Seattle, United States: Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the launch and availability of Evercode™ Low Input Fixation kits for both cells and nuclei. The new kits empower researchers who have a
Spinomenal Strengthens Demi Gods Series with Book of Demi Gods VI Title
Reading Time: 2 minutes Leading iGaming content provider Spinomenal has taken its Demi Gods series to new heights with the launch of its Book of Demi Gods VI. This Spinomenal tale takes place in the Ancient Asgardian Realm amongst golden halls and vast landscapes.
Lundin Gold Reports Additional High-Grade Drilling Intercepts at FDNS And Updates on Conversion Drilling Program
Reading Time: 14 minutes Recent drilling results confirm the continuity and growth potential of FDNS as a new high-grade system across the south of FDN VANCOUVER, BC, November 4, 2024 /CNW/ – Lundin Gold Inc. (TSX: LUG) (Nasdaq Stockholm: LUG) (OTCQX: LUGDF) (“Lundin Gold” or